Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients with MCRC
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Shanghai Henlius Biotech
Related studies linked through entity extraction aliases.
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Investigate the Safety, Tolerability and Efficacy of HLX60 Combination With HLX10 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of HLX35 in Combination With HLX10 in Patients With Advanced or Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers
- Status
- WITHDRAWN
- Phase
- PHASE1
Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)
- Status
- UNKNOWN
- Phase
- PHASE2